Suppr超能文献

移植存活由颗粒酶B+调节性细胞和适应性调节性T细胞维持。

Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

作者信息

Gondek David C, Devries Victor, Nowak Elizabeth C, Lu Li-Fan, Bennett Kathryn A, Scott Zachary A, Noelle Randolph J

机构信息

Department of Microbiology and Immunology, Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH 03756, USA.

出版信息

J Immunol. 2008 Oct 1;181(7):4752-60. doi: 10.4049/jimmunol.181.7.4752.

Abstract

Granzyme B (GZB) has been implicated as an effector mechanism in regulatory T cells (T(reg)) suppression. In a model of T(reg)-dependent graft tolerance, it is shown that GZB- deficient mice are unable to establish long-term tolerance. Moreover, mice overexpressing the inhibitor of GZB, serine protease inhibitor 6, are also resistant to tolerization to alloantigen. Graft survival was shorter in bone marrow-mixed chimeras reconstituted with GZB-deficient T(reg) as compared with wild-type T(reg). Whereas there was no difference in graft survival in mixed chimeras reconstituted with wild-type, perforin-deficient, or Fas ligand-deficient T(reg). Finally, data also show that if alloreactive effectors cannot express FoxP3 and be induced to convert in the presence of competent T(reg), then graft tolerance is lost. Our data are the first in vivo data to implicate GZB expression by T(reg) in sustaining long-lived graft survival.

摘要

颗粒酶B(GZB)被认为是调节性T细胞(T(reg))发挥抑制作用的一种效应机制。在一个T(reg)依赖的移植耐受模型中,研究表明GZB缺陷小鼠无法建立长期耐受。此外,过表达GZB抑制剂丝氨酸蛋白酶抑制剂6的小鼠也对同种异体抗原耐受具有抗性。与野生型T(reg)重建的骨髓混合嵌合体相比,用GZB缺陷的T(reg)重建的骨髓混合嵌合体的移植物存活时间更短。而用野生型、穿孔素缺陷型或Fas配体缺陷型T(reg)重建的混合嵌合体的移植物存活情况没有差异。最后,数据还表明,如果同种异体反应性效应细胞不能表达FoxP3,并且在有功能的T(reg)存在的情况下不能被诱导转化,那么移植耐受就会丧失。我们的数据是首次表明T(reg)表达GZB对维持长期移植物存活有影响的体内数据。

相似文献

1
Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.
J Immunol. 2008 Oct 1;181(7):4752-60. doi: 10.4049/jimmunol.181.7.4752.
2
Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.
Blood. 2010 Mar 4;115(9):1669-77. doi: 10.1182/blood-2009-07-233676. Epub 2009 Nov 13.
3
Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.
J Immunol. 2009 Jan 15;182(2):793-801. doi: 10.4049/jimmunol.182.2.793.
4
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
J Surg Res. 2012 Nov;178(1):133-8. doi: 10.1016/j.jss.2012.01.003. Epub 2012 Apr 1.
6
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
J Exp Med. 2013 Feb 11;210(2):257-68. doi: 10.1084/jem.20121525. Epub 2013 Feb 4.
7
Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x. Epub 2008 Jan 7.
8
Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance.
J Exp Med. 2011 Sep 26;208(10):2043-53. doi: 10.1084/jem.20110767. Epub 2011 Aug 29.
10
Granzyme B regulates antiviral CD8+ T cell responses.
J Immunol. 2011 Dec 15;187(12):6301-9. doi: 10.4049/jimmunol.1100891. Epub 2011 Nov 14.

引用本文的文献

1
CD137-expressing regulatory T cells in cancer and autoimmune diseases.
Mol Ther. 2025 Jan 8;33(1):51-70. doi: 10.1016/j.ymthe.2024.12.010. Epub 2024 Dec 11.
2
The biological function of Serpinb9 and Serpinb9-based therapy.
Front Immunol. 2024 Jun 20;15:1422113. doi: 10.3389/fimmu.2024.1422113. eCollection 2024.
3
Beyond Immune Balance: The Pivotal Role of Decidual Regulatory T Cells in Unexplained Recurrent Spontaneous Abortion.
J Inflamm Res. 2024 May 1;17:2697-2710. doi: 10.2147/JIR.S459263. eCollection 2024.
4
Recognizing Complexity of CD8 T Cells in Transplantation.
Transplantation. 2024 Nov 1;108(11):2186-2196. doi: 10.1097/TP.0000000000005001. Epub 2024 Apr 19.
6
Regulatory T cells in lung disease and transplantation.
Biosci Rep. 2023 Oct 31;43(10). doi: 10.1042/BSR20231331.
7
Reactive oxygen species formation and its effect on CD4 T cell-mediated inflammation.
Front Immunol. 2023 May 25;14:1199233. doi: 10.3389/fimmu.2023.1199233. eCollection 2023.
8
Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation .
Front Immunol. 2023 Mar 16;14:1139326. doi: 10.3389/fimmu.2023.1139326. eCollection 2023.
9
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses.
JCI Insight. 2022 Sep 8;7(17):e160674. doi: 10.1172/jci.insight.160674.
10
Cytolytic CD4 and CD8 Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease.
Front Immunol. 2022 Apr 12;13:864748. doi: 10.3389/fimmu.2022.864748. eCollection 2022.

本文引用的文献

1
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.
Immunity. 2007 Oct;27(4):635-46. doi: 10.1016/j.immuni.2007.08.014. Epub 2007 Oct 4.
3
Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. doi: 10.1073/pnas.0701171104. Epub 2007 Mar 26.
5
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
Nat Immunol. 2007 Feb;8(2):191-7. doi: 10.1038/ni1428. Epub 2006 Nov 30.
6
Mast cells are essential intermediaries in regulatory T-cell tolerance.
Nature. 2006 Aug 31;442(7106):997-1002. doi: 10.1038/nature05010. Epub 2006 Aug 20.
9
10
Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts.
Nat Immunol. 2006 Jun;7(6):652-62. doi: 10.1038/ni1333. Epub 2006 Apr 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验